loadpatents
name:-0.024326086044312
name:-0.029499053955078
name:-0.00078701972961426
Reddy; Rapolu Raji Patent Filings

Reddy; Rapolu Raji

Patent Applications and Registrations

Patent applications and USPTO patent grants for Reddy; Rapolu Raji.The latest application filed is for "polymorphs of darunavir".

Company Profile
0.16.18
  • Reddy; Rapolu Raji - Andrah Pradesh IN
  • Reddy; Rapolu Raji - Andhra Pradesh N/A IN
  • Reddy; Rapolu Raji - Hyderabad IN
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Polymorphs of darunavir
Grant 9,580,440 - Reddy , et al. February 28, 2
2017-02-28
Salts of raltegravir
Grant 8,962,833 - Reddy , et al. February 24, 2
2015-02-24
Crystalline hydrochloride salt of darunavir
Grant 8,853,430 - Reddy , et al. October 7, 2
2014-10-07
Polymorphs Of Darunavir
App 20140200356 - Reddy; Bandi Parthasaradhi ;   et al.
2014-07-17
Crystalline forms of maraviroc phosphate and process for maraviroc amorphous form
Grant 8,779,143 - Reddy , et al. July 15, 2
2014-07-15
Polymorphs of raltegravir potassium
Grant 8,742,105 - Reddy , et al. June 3, 2
2014-06-03
Hydrated form of erlotinib free base and a process for preparation of erlotinib hydrochloride polymorph form a substantially free of polymorph form B
Grant 8,669,265 - Reddy , et al. March 11, 2
2014-03-11
Process For Nucleosides
App 20140046062 - Reddy; Bandi Parthasaradhi ;   et al.
2014-02-13
Process For Purification Of Aprepitant
App 20130345418 - Reddy; Bandi Parthasaradhi ;   et al.
2013-12-26
Novel Hydrated Form of Erlotinib Free Base and a Process For Preparation Of Erlotinib Hydrochloride Polymorph Form A Substantially Free of Polymorph Form B
App 20130252978 - REDDY; BANDI PARTHASARADHI ;   et al.
2013-09-26
Crystalline Forms Of Maraviroc Phosphate And Process For Maraviroc Amorphous Form
App 20130211091 - Reddy; Bandi Parthasaradhi ;   et al.
2013-08-15
Salts Of Lapatinib
App 20130131090 - Reddy; Bandi Parthasaradhi ;   et al.
2013-05-23
Polymorphs of sunitinib malate
Grant 8,329,740 - Reddy , et al. December 11, 2
2012-12-11
Stereoselective synthesis of benzimidazole sulfoxides
Grant 8,173,817 - Reddy , et al. May 8, 2
2012-05-08
Stereoselective synthesis of benzimidazole sulfoxides
Grant 7,928,241 - Reddy , et al. April 19, 2
2011-04-19
Process of making sertraline form II
Grant 7,772,437 - Reddy , et al. August 10, 2
2010-08-10
Process of making sertraline form I
Grant 7,772,438 - Reddy , et al. August 10, 2
2010-08-10
Pharmaceutical Compositions Of Valdecoxib
App 20090227645 - Reddy; Bandi Parthasaradhi ;   et al.
2009-09-10
Process Of Making Sertraline Form Ii
App 20090177009 - Reddy; Bandi Parthasaradhi ;   et al.
2009-07-09
Process Of Making Sertraline Form I
App 20090177010 - Reddy; Bandi Parthasaradhi ;   et al.
2009-07-09
Polymorphs of tolterodine tartrate
Grant 7,393,874 - Reddy , et al. July 1, 2
2008-07-01
Novel Stereoselective Synthesis Of Benzimidazole Sulfoxides
App 20080076929 - Reddy; Bandi Parthasaradhi ;   et al.
2008-03-27
Novel Stereoselective Synthesis Of Benzimidazole Sulfoxides
App 20080076930 - Reddy; Bandi Parthasaradhi ;   et al.
2008-03-27
Novel processes for preparing sertraline hydrochloride crystalline forms
App 20070282129 - Reddy; Bandi Parthasaradhi ;   et al.
2007-12-06
Novel Process For Preparation Of Substituted Sulfoxides
App 20070129405 - REDDY; Bandi Parthasaradhi ;   et al.
2007-06-07
Novel process for preparation of valsartan
App 20060100443 - Parthasaradhi Reddy; Bandi ;   et al.
2006-05-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed